Jinhe Biotechnology Co (SZSE:002688) Accounts Payable & Accrued Expense : ¥413 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Accounts Payable & Accrued Expense?

Jinhe Biotechnology Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥349 Mil) to Dec. 2023 (¥449 Mil) but then declined from Dec. 2023 (¥449 Mil) to Mar. 2024 (¥413 Mil).

Jinhe Biotechnology Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥179 Mil) to Dec. 2022 (¥330 Mil) and increased from Dec. 2022 (¥330 Mil) to Dec. 2023 (¥449 Mil).

Jinhe Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jinhe Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Accounts Payable & Accrued Expense Chart

Jinhe Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

196.71

148.96

178.84

329.63

449.25

Jinhe Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															269.09	415.21	349.17	449.25	413.18

Jinhe Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jinhe Biotechnology Co (SZSE:002688) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Zone B3 Xinghai Plaza, 1-7-2 Building 27, Shahekou District, Dalian, CHN, 116023

Website

http://www.jinhe.com.cn

Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatment business.

Executives

Wang Zhi Jun	Directors, executives
Liu Ying Chun	Executives
Deng Yi Xin	Secretary Dong
Li Fu Zhong	Director
Liu Yun Tian	Directors, executives
Xie Chang Xian	Directors, executives
Wang Dong Xiao	Director
Yao Jian Xiong	Supervisors
Zheng Liu Ji	Supervisors
Niu You Shan	Executives
Wu Ming Xia	Director
Li Wei Qi	Directors, executives
Wu Rui Gang	Executives

Jinhe Biotechnology Co (SZSE:002688) Headlines

No Headlines